UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

SUBMIT
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

ASTM International - ASTM F1830-97(2017)

Standard Practice for Selection of Blood for in vitro Evaluation of Blood Pumps

inactive
Buy Now
Organization: ASTM International
Publication Date: 1 September 2017
Status: inactive
Page Count: 3
ICS Code (Laboratory medicine): 11.100
significance And Use:

5.1 The test results are substantially affected by donor species and age, the method of harvesting, the period of storage, the biochemical state of the blood, and the hemoglobin and hematocrit... View More

scope:

1.1 This practice covers blood that will be used for in vitro performance assessments of blood pumps. These assessments include the hemolytic properties of the devices.

1.2 This practice covers the utilization of blood for the in vitro evaluation of the following devices:

1.2.1 Continuous flow rotary blood pumps (roller pumps, centrifugal pumps, axial flow pumps, and so forth) (see Practice F1841).

1.2.2 Pulsatile blood pumps (pneumatically driven, electromechanically driven, and so forth).

1.3 The source of blood utilized for in vitro evaluation of blood trauma (that is, hemolysis caused by the blood pumps, due to the pump design, construction, and materials used) substantially influences the results of the performance of these devices. Thus, a standardized blood source is required.

1.4 The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.

1.5 This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

Document History

September 1, 2019
Standard Practice for Collection and Preparation of Blood for Dynamic in vitro Evaluation of Hemolysis in Blood Pumps
1.1 This practice covers whole blood that will be used for the in vitro performance assessment of hemolysis in blood pumps intended for clinical use. 1.2 This practice covers the recommended...
ASTM F1830-97(2017)
September 1, 2017
Standard Practice for Selection of Blood for in vitro Evaluation of Blood Pumps
1.1 This practice covers blood that will be used for in vitro performance assessments of blood pumps. These assessments include the hemolytic properties of the devices. 1.2 This practice covers the...
March 1, 2013
Standard Practice for Selection of Blood for in vitro Evaluation of Blood Pumps
1.1 This practice covers blood that will be used for in vitro performance assessments of blood pumps. These assessments include the hemolytic properties of the devices. 1.2 This practice covers the...
March 1, 2005
Standard Practice for Selection of Blood for in vitro Evaluation of Blood Pumps
1.1 This practice covers blood that will be used for in vitro performance assessments of blood pumps. These assessments include the hemolytic properties of the devices. 1.2 This practice covers the...
January 1, 1997
Standard Practice for Selection of Blood for In Vitro Evaluation of Blood Pumps
1.1 This practice covers blood that will be used for in vitro performance assessments of blood pumps. These assessments include the hemolytic properties of the devices.
Advertisement